Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2017 May 9;26(7):819–826. doi: 10.1002/pds.4224

Table 2.

Unadjusted and adjusted results of predictors of annual generic drug prescribing rates (n=770,095)

Factors Mean Annual Generic Drug Prescribing Rate
Rate Ratio (99% Confidence Interval)1
Unadjusted Models2 Adjusted Model3
Industry payments category
 No payment ref ref
 $100 and less 0.96 (0.96, 0.96)** 0.98 (0.97, 0.98)**
 $100-500 0.93 (0.92, 0.93)** 0.95 (0.95, 0.95)**
 More than $500 0.92 (0.92, 0.92)** 0.95 (0.95, 0.95)**
Prescriber characteristics
 Sex
  Male ref ref
  Female 0.99 (0.99, 0.99)** 0.97 (0.97, 0.97)**
 Region
  Northeast ref ref
  Midwest 1.05 (1.04, 1.05)** 1.05 (1.04, 1.05)**
  South 1.03 (1.03, 1.03)** 1.03 (1.03, 1.03)**
  West 1.03 (1.02, 1.03)** 1.02 (1.02, 1.02)**
  Non-US 1.06 (1.05, 1.07)** 1.06 (1.05, 1.07)**
Prescriber practice factors
 Specialty
  Primary care ref ref
  Medical specialty 0.91 (0.91, 0.91)** 0.92 (0.91, 0.92)**
  Surgical specialty 0.93 (0.92, 0.93)** 0.93 (0.92, 0.93)**
  Obstetrics/gynecology 0.81 (0.80, 0.81)** 0.82 (0.81, 0.82)**
  Hospital-based specialty 1.09 (1.09, 1.09)** 1.07 (1.07, 1.08)**
  Psychiatry 1.05 (1.05, 1.05)** 1.06 (1.06, 1.06)**
  Non-physician, unknown 1.02 (1.01, 1.02)** 1.01 (1.01, 1.01)**
 Annual number of distinct Medicare Part D beneficiaries served
  0-50 ref ref
  51-100 1.00 (1.00, 1.00)* 1.01 (1.01, 1.01)**
  101-250 1.01 (1.01, 1.02)** 1.02 (1.02, 1.03)**
  251 and above 0.98 (0.98, 0.98)** 1.00 (1.00, 1.01)**
1

Generalized linear regression models with Poisson distribution

2

Each factor as the only exposure variable without controlling for any other factors

3

Industry payments as exposure variable, controlling for all covariates

*

P<0.01

**

P<0.001